We only have this paper's title and publication details.
Read it at the sourceArtesunate has anti-proliferative properties in CRC and is generally well tolerated.
No takes yet. Share an insight, caveat, or question.
Krishna et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: